Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.
Quote | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Last: | $8.12 |
---|---|
Change Percent: | 0.0% |
Open: | $8 |
Close: | $8.12 |
High: | $8.155 |
Low: | $7.9187 |
Volume: | 906,936 |
Last Trade Date Time: | 04/29/2025 03:40:37 pm |
News | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder Services (“ISS”) has recommended that Aurinia shareholders vote FOR all proposals put forth by the Bo...
2025-04-26 10:54:05 ET Summary AUPH has seen some management changes, but activist investors demand more despite steady Lupkynis sales growth. The first quarter was strong in terms of sales in 2023 and 2024, and upcoming Q1 '25 earnings represent an opportunity to confirm that tre...
Message Board Posts | Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Subject | By | Source | When |
---|---|---|---|
Ha! | Ganz | investorshub | 04/30/2023 4:23:08 PM |
I did the same and I have a | kipster210 | investorshub | 04/29/2023 9:45:03 PM |
Just voted NO on everything management wants and | Benny450 | investorshub | 04/29/2023 8:49:52 PM |
They probably tallying up the votes and it | Cosa | investorshub | 04/28/2023 10:21:53 PM |
I would never touch that shitplaying right into | greggors | investorshub | 04/28/2023 9:55:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Aurinia Pharmaceuticals Inc Company Name:
AUPH Stock Symbol:
NASDAQ Market:
0.0% G/L:
$8.12 Last:
906,936 Volume:
$8 Open:
$8.12 Close:
Aurinia Pharmaceuticals Inc Website:
Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder Services (“ISS”) has recommended that Aurinia shareholders vote FOR all proposals put forth by the Bo...
2025-04-04 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
FTAI Infrastructure Inc. (FIP) is expected to report for quarter end 2024-12-31 Nautilus Biotechnology Inc. (NAUT) is expected to report $-0.16 for Q4 2024 Falconstor Software Inc (FALC) is expected to report for quarter end 2024-12-31 Payoneer Global Inc. (PAYO) is expected to report...